Back to results
US 6,555,314 B1Granted
Toso as a target for drug screening
AssigneeRigel Pharmaceuticals, Inc.
InventorDonald Payan
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods for identifying novel compositions which modulate the activity of Toso, and the use of such compositions in diagnosis and treatment of disease.
Claims9
A method for screening for a bioactive agent capable of modulating the activity of a Toso cell-surface receptor, said method comprising the steps of:
- a) adding a candidate bioactive agent to a cell comprising a recombinant nucleic acid encoding a Toso cell-surface receptor, wherein said recombinant nucleic acid will hybridize under high stringency conditions to the nucleic acid sequence depicted in FIG. 1 (SEQ ID NO:1) or its complement;
- 0
- b) exposing said cell to an apoptotic agent that will induce apoptosis;
- and
- c) determining the effect of the candidate bioactive agent on apoptosis.
2 more elements
Dependencies are inferred from the claim text.